Clinical trial
QUALITY OF LIFE ASSESSMENT IN PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROME
NCT00967564 is registered in ClinicalTrials.gov with Janssen-Cilag S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- QUALITY OF LIFE ASSESSMENT IN PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROME
- Lead sponsor
- Janssen-Cilag S.p.A.
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2007
- Completion date
- November 30, 2009
- Enrollment
- 160 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.